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Abstract
Background
Non-modifiable patient characteristics, including age, gender, ethnicity as well as the occur-
rence of multi-morbidities, are associated with processes and outcomes of diabetes care.
Information on these factors can be used in case mix adjustment of performance measures.
However, the practical relevance of such adjustment is not clear. The aim of this study was
to assess the strength of associations between patient factors and diabetes care processes
and outcomes.
Methods
We performed an observational study based on routinely collected data of 12,498 diabetes
patients in 59 Dutch primary care practices. Data were collected on patient age, gender,
whether the patient lived in a deprived area, body mass index and the co-occurrence of car-
diovascular disease, chronic obstructive pulmonary disease, depression or anxiety. Out-
comes included 6 dichotomous measures (3 process and 3 outcome related) regarding
glycosylated hemoglobin, systolic blood pressure and low density lipoprotein-cholesterol.
We performed separate hierarchical logistic mixed model regression models for each of the
outcome measures.
Results
Each of the process measure models showed moderate effect sizes, with pooled areas
under the curve that varied between 0.66 and 0.76. The frequency of diabetes related con-
sultations as a measure of patient compliance to treatment showed the strongest associa-
tion with all process measures (odds ratios between 5.6 and 14.5). The effect sizes of the
outcome measure models were considerably smaller than the process measure models,
with pooled areas under the curve varying from 0.57 to 0.61.
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Conclusions
Several non-modifiable patient factors could be associated with processes and outcomes of
diabetes care. However, associations were small. These results suggest that case-mix cor-
rection or stratification in assessing diabetes care has limited practical relevance.
Introduction
Many quality programs for diabetes care aim at improving clinical processes and outcomes [1].
An important part of the goals set in these programs is the prevention of cardiovascular risk
[2,3]. Relevant intermediate outcomes include glycated hemoglobin (HbA1c), blood pressure
and serum cholesterol values. These outcome measures are associated with a range of non-
modifiable patient characteristics, including gender, age, ethnicity and other socio-demograph-
ic factors [4–7]. For example, women in diabetes care have higher blood pressure and serum
cholesterol levels compared to men [7]. In order to compare performance measures between
practices, adjustment is suggested for these factors, as they could be unequally distributed in
the different populations assessed [8]. Zaslavsky et al. [9] showed that adjustment for socio-de-
mographic factors had little impact on most performance measures, but larger impact on a few
measures, particularly when the measure involved a relatively large percentage of patients from
a minority ethnic group. However, case mix adjustment is not consistently applied, possibly
due to differential perspectives and uncertainties about when and how to adjust [10].
Besides socio-demographic factors, differences in the severity of the condition can be associ-
ated with diabetes control as well. The severity of diabetes mellitus can be defined as the co-oc-
currence of other conditions. In this article we focus on multi-morbidity, which can be defined
as 'any co-occurrence of medical conditions within a person' [11]. The number of patients with
multi-morbidity has risen enormously in the past decades [12]. A systematic review [13]
showed that conditions that often occur in diabetes patients include cardiovascular diseases
(CVD), depression and cancer. These conditions may be directly related to diabetes (e.g. CVD)
or indirectly related (e.g. chronic obstructive pulmonary disease, COPD) [14]. Several studies
have shown that the presence of different types of multi-morbid conditions (in several patient
groups, including patients with diabetes) can lead to better cardiovascular risk control, both re-
garding processes and outcomes of care [15–17]. Multi-morbidity may lead to lowered patient
compliance with treatment and advice [18,19]. Turner et al. [20] found that the relationship be-
tween multi-morbidity and healthcare outcomes may vary, depending on how closely related
the conditions are. They suggest that related multi-morbid conditions may lead to improved
care delivery, whereas unrelated multi-morbid conditions may have a negative impact on
health outcomes [20]. Voorham et al. [21]specifically looked at the effects of multi-morbidity
on medication treatment and found that diabetes-related multi-morbidity could induce treat-
ment intensification for cardiovascular risk factors.
Information on multi-morbidity can be used in case mix adjustment of performance mea-
sures. However, the strength of the association between multi-morbidity factors, other case
mix factors and measures of processes and outcomes of care is not clear. Therefore, the aim of
this study was to (1) identify which patient factors and prevalent multi-morbid conditions are
related to processes and outcomes of diabetes care, (2) how strong these associations are, and
(3) the relative importance of the factors identified as predictors.
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Methods
The research was conducted under supervision of IQ healthcare, a scientific department focus-
ing on quality improvement in healthcare, and as such forms part of the Radboud University
Medical Centre in Nijmegen, the Netherlands. LINH is registered with the Dutch Data Protec-
tion Authority and data are handled according to the national data protection guidelines. The
study was conducted in accordance with the Dutch Law for the Protection of Personal Data
(Wet Bescherming Persoonsgegevens)[22] and the Declaration of Helsinki [23]. Based on the
Dutch Law for the Protection of Personal Data no medical ethical committee approval was re-
quired for this study, therefore the medical ethical committee was not contacted. All data were
anonymized before extraction and analysis.
Data availability statement
Due to ethical restrictions, data are available from the Netherlands Information Network of Gen-
eral Practice (LINH). An English application form for the use of data can be found at http://
www.nivel.nl/sites/default/files/bestanden/LINH-formulier_gegevensaanvraag_engels.rtf. Crite-
ria for data access are displayed on this form. All data were anonymized before data extraction
and analysis.
Study design and population
We performed an observational study based on routinely collected data from Dutch primary
care practices. In the Netherlands, routine diabetes care is primarily provided in general prac-
tice; therefore, in our study we focus solely on primary care. All data were collected as part of a
national representative network of practices (LINH), in which data were extracted from the
electronic patient records. In total, a sample of 12498 diabetes patients from 59 general prac-
tices was included in this study. All practices extracted their data in the year 2010. The extrac-
tion included information from all contacts with a time window of one year. This time period
was based on the fact that all measures included in the study should be measured at least once
a year according to the guidelines.
Measures
We included demographic patient characteristics and information on prevalent multi-morbidi-
ties in the study. Data were collected on patient age, gender, whether the patient lived in a de-
prived area and body mass index (BMI). A systematic review showed that out of all conditions
that are commonly treated in primary care, CVD, COPD, depression and anxiety most often
co-occur with diabetes [13]. Information on multi-morbidity was based on the ICPC codes
[24], and included as a dichotomous variable for each condition. CVD included ischaemic
heart disease with or without angina, acute myocardial infarction, heart failure, atrial fibrilla-
tion, hypertension, transient cerebral ischaemia, cerebrovascular disease, stroke and atheroscle-
rosis. Anxiety and depression included the ICPC codes for feeling depressed, anxiety disorder
or anxiety state and depressive disorder. Furthermore, the number of diabetes related consulta-
tions per year was included. Whenever the ICPC code for diabetes was recorded in the medical
record, the consultation was recorded as diabetes related. Consultations can be provided by the
general practitioner or other staff in the general practice, including a nurse practitioner. In this
study, we only included the frequency of the consultations; we did not have information on the
caregiver that provided the consultation. We also recorded whether patients received a pre-
scription of lipid lowering medication, anti-diabetic medicine (oral, insulin or both) or blood
pressure lowering medication.
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Outcome measures included 6 dichotomous measures regarding glycosylated hemoglobin
(HbA1c), systolic blood pressure (BP) and low density lipoprotein-cholesterol (LDL-C). We in-
cluded whether the target level (as set in the Dutch guideline [25]) was measured during con-
sultation (yes/no) and, for those cases with a valid measurement, whether it was achieved (yes/
no). The most recent valid data for each patient were included in the dataset.
Analyses
Descriptive statistics were used to describe the patient and practice characteristics. A missing
data analysis was performed since length and weight (to calculate BMI) were not recorded
structurally each year. We performed multiple imputation to complete missing values on BMI
data, using 5 imputation sets. A larger number of imputation sets has been recommended.
However, since our dataset consisted of a large number of patients, the difficulties of applying a
large number of imputation sets (>10) in a reasonable amount of time outweighed the benefits.
Practices, main outcomes and predictors were included in de imputation models. We also in-
cluded practice in the imputation models to account for clustering effects.
To assess which patient factors were associated with clinical processes and outcomes of dia-
betes care, logistic mixed models were performed on the imputation models in order to obtain
pooled results, taking into account the clustering of patients within practices. We ran six sepa-
rate hierarchical logistic regression models, one for each of the outcome measures (HbA1c,
BP and LDL-C measured, HbA1c, BP and LDL-C within target level). Target levels were set at
53 mmol/mol, 140 mm Hg and 2.5 mmol/l respectively. In each model, we included patient
age, gender, number of diabetes related consults (above or below median), whether the patient
lives in deprived area, BMI and presence of ICPC code related to CVD, COPD and / or depres-
sion and anxiety (dichotomous measures). We assessed the discriminative power of the model
by calculating the area under the curve in the imputation sets (pooled AUC) and we also calcu-
lated pooled fixed effects (OR). In order to assess whether specific factors can be left out from
the model without decreasing the effect size, we then reduced each of the 6 models in accor-
dance with the maximum log-likelihood test (p<0.10) and again calculated pooled fixed effects
and pooled AUC's. The multiple imputation and logistic multilevel models were performed in
R version 3.03. Descriptive statistics were performed in SPSS version 20.
Results
Study population and measures
11,718 out of 12,498 patients from 59 practices were included in the analyses of process mea-
sures. 689 patients were excluded because they were in hospital care instead of primary care, 91
patients were excluded due to age (younger than 18 years). This population is a reasonable re-
presentation of all Dutch diabetes patients in primary care Table 1. Subsets of 8028, 8936 and
9257 patients were included in the analysis of outcome measures on LDL cholesterol, HbA1c
and systolic blood pressure respectively. The percentage of patients with outcomes below target
level was slightly lower than the percentages found in a Dutch multidisciplinary care study;
however, in the latter, practices could exclude particular patient groups that are more difficult
to treat. Also, the study population scored substantially lower on the registration of the patient
outcomes. In Table 2, we report the variation on the process measures across the 59 practices.
We found that for each of the process measures, the variation between practices is sufficiently
large to show possible effects of patient determinants.
In our missing data analysis we found that as expected the main measure with missing data
was BMI (3436 missing, 29.3%). Other variables with missing data included age (1 missing,
Patient Characteristics Associated with Diabetes Care
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Table 1. Patient characteristics and overall scores on indicators.
patient characteristics study population Dutch diabetes population^,A,B,D
N 11,718 834,100
Women 49.8% 50.1%
mean age (SD) 65.8 (13.3) 67.7 (12.6)
mean Body Mass Index (SD) 29.6 (5.3) -
patients with funds for deprived areas 5.9% -
mean number of consultations per year (SD) 7.6 (6.9) -
mean number of DM related consultations per year (SD) 2.8 (3.4) -
multi-morbid conditions
a) cvd 69.8% -
b) COPD 8.5% 8.4%
c) depression and anxiety 13.2% 17.6%
medication prescriptions
antidiabetic medicine
a) no medication 31.3% 22%
b) oral medication only 52.3% 62%
c) oral medication and insulin 10.4% 10%
d) insulin only 6.0% 4%
blood pressure lowering medication 69.3% -
cholesterol lowering medication 64.0% 67.0%
indicator outcomes study population Dutch studymultidisciplinary careC
HbA1c value measured 76.7% 91.4%
mean HbA1c value (SD) 50.8 (11.8) -
HbA1c value below target level (53) 67.3% 68.8%
systolic blood pressure measured 79.0% 89.9%
mean systolic blood pressure value (SD) 140.3 (18.1) -
systolic blood pressure below target level (140) 49.1% 52.3%
LDL cholesterol level measured 69.4% 85.3%
mean LDL cholesterol level (SD) 2.59 (.93) -
LDL cholesterol level below target level (2.5) 49.6% 53.1%
source data on the Dutch population:
A. RIVM. National Compass Population Health (Nationaal Kompas Volksgezondheid). 2011 [6–19–14]; Available from: http://www.nationaalkompas.nl/
gezondheid-en-ziekte/ziekten-en-aandoeningen/endocriene-voedings-en-stofwisselingsziekten-en-immuniteitsstoornissen/diabetes-mellitus/omvang/.
B. Ubink-Veltmaat LJ, Bilo HJ, Groenier KH, Houweling ST, Rischen RO, Meyboom-de Jong B. Prevalence, incidence and mortality of type 2 diabetes
mellitus revisited: a prospective population-based study in The Netherlands (ZODIAC-1). European journal of epidemiology. 2003;18(8):793–800. Epub
2003/09/17.
C. Transparancy in multidisciplinary care. In Dutch: Transparantie ketenzorg Diabetes Mellitus. Rapportage zorggroepen 2010. Utrecht, The Netherlands:
Dutch National Organization for multidisciplinary care, 2012.
D. van Doorn-Klomberg A, Braspenning J, Bouma M. Report Dutch Practice Accreditation. Medical care in 2012. In Dutch: Rapportage
NHG-Praktijkaccreditering: gegevens over het medisch handelen in 2012. Nijmegen, The Netherlands: Radboud University Medical Center, IQ healthcare,
2013.
^ Several characteristics of our study population could not be contrasted with the Dutch population or other comparable study populations because no
suitable data could be found.
doi:10.1371/journal.pone.0121845.t001
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0.01%) and whether the patient lives in a deprived area (81 missing, 0.69%). Results from a
MCAR test showed that the missing data were not completely at random.
Multilevel logistic regression analyses process measures
Each of the process measure models showed moderate effect sizes, with pooled areas under the
curve (AUCs) that varied between 0.66 and 0.76. The closer the AUC value approaches 1, the
better the model can distinguish whether processes are performed or not based on the factors
included in the model. An AUC of 0.5 would indicate that the model does not perform better
than chance. A pooled AUC of. 76 indicates that for each pair of patients (one with processes
performed and one without processes performed), the model could classify these correctly in
76% of the cases. The effect sizes could be maintained with a reduced model. In the complete
models, HbA1c, systolic blood pressure and LDL cholesterol values were measured more often
in older patients, see Table 3. Furthermore, patients with CVD more often had their outcomes
measured, with the largest odds for measurement of blood pressure (OR 1.75, 95% CI 1.56–
1.98). In other words, as a diabetes patient with CVD as multi-morbidity, the odds of having
your blood pressure measured were 1.75 times higher than for diabetes patients without CVD.
On the other hand, patients with COPD had a lower probability to have their blood pressure
measured (OR 0.72, 95% CI 0.59–0.87). COPD patients also had a smaller probability of
HbA1c and LDL cholesterol measurements compared to patients without COPD. For each of
the three process measures there was an association of the frequency of diabetes related consul-
tations and the probability of the value being measured (ORs vary between 5.6 and 14.5). In
fact, this factor on its own explained a large part of the effects found in the models (pooled
AUC between 0.66 and 0.71) compared to models that included all factors (pooled AUC be-
tween 0.70 and 0.76).
Multilevel logistic regression analyses outcome measures
The effect sizes of the outcome measure models were considerably smaller than the process
measure models, with pooled AUCs varying from 0.57 to 0.61. This indicates that the model
did not perform much better than chance. The probability of achieving the systolic blood pres-
sure target level was higher in older patients, while the probability of an LDL cholesterol level
within target was lower in older patients Table 4. Gender was also associated with outcomes,
with lower probabilities of good HbA1c and blood pressure control and a higher probability of
good LDL cholesterol control in male patients compared to female patients. Patients with CVD
had a higher probability that the HbA1c level was within target level and a lower probability
that the blood pressure was within target level. Patients with depression and anxiety also had a
higher probability of achieving an HbA1c level within target level. Furthermore, these patients
had a lower probability of achieving good LDL cholesterol control. Blood pressure and HbA1c
levels were less often below target level in patients with a higher BMI. A relatively high number
Table 2. Variations in clustered scores (per practice) on process indicators.
indicator outcomes study population
HbA1c value measured mean 76.0%
SD (range) 10.2% (50.8–96.7)
systolic blood pressure measured mean 76.9%
SD (range) 15.0% (7.0–96.9)
LDL cholesterol level measured mean 67.0%
SD (range) 18.3% (2.0–93.1)
doi:10.1371/journal.pone.0121845.t002
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of diabetes consultations was associated with poorer HbA1c control and better LDL cholesterol
control.
Discussion
In this study the associations between several non-modifiable patient characteristics and prevalent
multi-morbidities with processes and outcomes of diabetes care in Dutch general practices were
explored. We found that the models on processes of care showed moderate effects, suggesting that
Table 3. Factors associated with indicator processes: measure recorded within study period.
complete model reduced model DM consultation
only model
Factor# OR 95% CI OR 95% CI OR 95% CI
hbA1c
age in years 1.03 1.03–1.03 1.03 1.02–1.03 - -
gender male 1.01 0.92–1.12 - - - -
patient in deprived area 1.03 0.78–1.36 - - - -
cvd 1.15 1.03–1.29 1.17 1.05–1.31 - -
depression and anxiety 1.08 0.93–1.25 - - - -
COPD 0.81 0.67–0.97 0.81 0.68–0.97 - -
body mass index in kg/m2 1.01 1.00–1.03 - - - -
DM consultation count above median 14.4 12.3–16.7 14.4 12.3–16.8 15.4 13.2–17.9
AUC 0.76 0.76 0.71
N 11718 11718 11718
systolic blood pressure
age in years 1.03 1.03–1.04 1.03 1.03–1.04 - -
gender male 1.04 0.93–1.16 - - - -
patient in deprived area 1.11 0.83–1.49 - - - -
cvd 1.75 1.56–1.98 1.77 1.57–1.99 - -
depression and anxiety 0.93 0.80–1.09 - - - -
COPD 0.72 0.59–0.87 0.72 0.59–0.87 - -
body mass index in kg/m2 1.01 0.99–1.02 - - - -
DM consultation count above median 14.5 12.3–17.1 14.5 12.3–17.1 15.5 13.1–18.2
AUC 0.77 0.77 0.71
N 11718 11718 11718
LDL cholesterol
age in years 1.02 1.01–1.02 1.02 1.01–1.02 - -
gender male 1.17 1.06–1.29 1.16 1.06–1.27 - -
patient in deprived area 0.87 0.66–1.13 - - - -
cvd 1.31 1.18–1.46 1.32 1.19–1.47 - -
depression and anxiety 1.03 0.90–1.18 - - - -
COPD 0.81 0.69–0.95 0.81 0.69–0.95 - -
body mass index in kg/m2 1.00 0.99–1.02 - - - -
DM consultation count above median 5.60 4.99–6.28 5.61 5.00–6.30 5.92 5.28–6.63
AUC 0.70 0.69 0.66
N 11718 11718 11718
# reference categories: female, less than median diabetes related contacts per year, without funds for
deprived area, no multi-morbidities.
doi:10.1371/journal.pone.0121845.t003
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patient factors had some impact on diabetes care indicators. On the other hand, effects on out-
come measures were small. Measurement of the number of diabetes consultations, as a measure
of patient health service utilization, was the main contributor to the effects found.
Explanation of findings
Factors incorporated in our study only had small to moderate pooled effects on processes and
outcomes of care. This is in line with a study by Marceau et al. [26], who reported that from the
21.1% of variance in diabetes management that could be explained by patient, provider and
Table 4. Factors associated with indicator outcomes: outcome within target level.
complete model reduced model
Factor# OR 95% CI OR 95% CI
hbA1c
age in years 1.00 1.00–1.01 1.01 1.00–1.01
gender male 0.83 0.75–0.91 0.83 0.75–0.91
patient in deprived area 0.84 0.65–1.07 - -
cvd 1.10 0.99–1.23 - -
depression and anxiety 1.19 1.03–1.36 1.18 1.03–1.36
COPD 0.95 0.81–1.12 - -
body mass index in kg/m2 0.97 0.96–0.98 0.97 0.96–0.98
DM consultation count above median 0.54 0.48–0.60 0.54 0.48–0.60
AUC 0.59 0.58
N 8936 8936
systolic blood pressure
age in years 0.97 0.97–0.98 0.97 0.97–0.98
gender male 0.92 0.84–1.00 0.92 0.84–1.00
patient in deprived area 0.92 0.71–1.18 - -
cvd 0.54 0.49–0.60 0.54 0.49–0.60
depression and anxiety 1.07 0.94–1.21 - -
COPD 1.13 0.97–1.31 - -
body mass index in kg/m2 0.97 0.96–0.98 0.97 0.96–0.98
DM consultation count above median 1.04 0.94–1.16 - -
AUC 0.61 0.61
N 9257 9257
LDL cholesterol
age in years 1.01 1.01–1.02 1.01 1.01–1.01
gender male 1.47 1.34–1.62 1.45 1.33–1.59
patient in deprived area 1.44 1.09–1.89 1.44 1.10–1.90
cvd 1.19 1.07–1.32 1.20 1.08–1.34
depression and anxiety 0.84 0.74–0.96 0.84 0.74–0.96
COPD 1.03 0.87–1.21 - -
body mass index in kg/m2 1.01 1.00–1.02 - -
DM consultation count above median 1.33 1.19–1.48 1.33 1.19–1.48
AUC 0.57 0.57
N 8028 8028
# reference categories: female, less than median diabetes related contacts per year, without funds for
deprived area, no multi-morbidities.
doi:10.1371/journal.pone.0121845.t004
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organizational factors, only 2.2% could be explained by patient factors. The main contributor
was the diabetes consultation frequency. Since in general all patients receive automated invita-
tions for their 3-monthly and yearly consultations, this measure reflects patients’ attitudes and
compliance. The effects found are in line with other literature that shows that poor adherence
to treatment plans (such as failure to come to an appointment) can have negative effects on
processes and outcomes of care [27].
Since effect sizes found are moderate to small, it may be debated whether to take these case
mix factors into account in the calculation of scores on population level, either through correc-
tion or stratification. The small changes in scores may not weigh up against the troubles of data
collection and increased complexity of score interpretation. Furthermore, Nicholl [28] suggests
that correction can actually increase the bias in measurements, especially when interactions be-
tween factors are not taken into account properly. However, it is possible that other patient fac-
tors than in this study are relevant for diabetes care processes and outcomes, or that the
examined factors are relevant for health outcomes that were not examined in this study. Also,
for the evaluation of individual patients it is important to be aware of the possible risk factors,
since they may have large influence in a single patient. Furthermore, when the total number of
diabetes patients in a practice is relatively small, one should account for a larger variation in
the score [29]. In such case, we suggest that accounting for a larger error margin is better than
correcting for multiple factors, since this will only increase the bias due to the lower precision
of the data.
Results on measurement of outcomes are in line with previous literature that shows that the
influence of a multi-morbidity depends on whether the conditions are strongly related to each
other [20]. We found that in patients with COPD, a condition that is less strongly related to
diabetes, processes of care were less often according to the guidelines. It is possible that during
consultations with COPD patients, priority is given to address those issues that cause the high-
est burden on the patient quality of life the most. These issues are more likely to be COPD
related rather than diabetes related. On the other hand, patients with a strongly related condi-
tion, CVD, were more likely to have their blood pressure measured. Results are similar to a
Dutch study by Nouwens et al., in which better cardiovascular risk treatment in diabetes pa-
tients but not in COPD patients was reported [16]. Our findings are also in line with the study
by Voorham et al. [21]. They looked at the association between multi-morbidity and treatment
intensification. In their study, new occurrences of diabetes-related multi-morbidities such as
cardiovascular disease were related with better risk factor treatment, whereas no effects were
found for non-diabetes related multi-morbidities.
Our results show that patients with depression and anxiety have a higher probability to have
good HbA1c control than others, whereas the probability is lowered that they have good cho-
lesterol control. Although literature shows that depression is associated with poorer medication
adherence [30], evidence regarding the effects on HbA1c, blood pressure and cholesterol con-
trol is inconclusive [31,32]. Possibly patients with anxiety are more sensitive for side-effects of
lipid lowering medication, resulting in poor cholesterol control.
Strengths and limitations
In this observational study, there were several factors associated with diabetes care that we could
not take into account. These include hereditary factors and lifestyle factors, which have known as-
sociations with development of diabetes [33]. We also did not include duration and severity of the
illness in our study, which is an important limitation. Furthermore, medication compliance may
have varied between patients, which may have also influenced the scores. Other studies show that
longer diabetes duration is associated with more diabetes complications such as retinopathy [34]
Patient Characteristics Associated with Diabetes Care
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and coronary heart disease [35]. These factors may explain part of the variation that we could not
account for with our model. Poor outcomes of care may be accounted for by factors that we did
not include in our dataset, including presence of pancreatic illnesses or issues with medication tol-
erance. However, these factors only regard small parts of the population of diabetic patients seen
by the general practitioner. Therefore, we expect that this has not had a large influence on our
study.
Our study was performed on a large dataset that formed an adequate reflection of the diabe-
tes patients treated in primary care. There were several limitations to the use of this dataset.
We could only analyze the outcomes of care for those patients that had a measurement of the
outcome, i.e. scored positively on the process measure. This can cause a bias in our study. It
may be the case that practitioners are more likely to perform measurements when they expect
that patients need treatment; leading to a slightly lower percentage of patients with a measure-
ment within target level compared to those without a measurement. On the other hand, there
may have been an underrepresentation of patients that show higher noncompliance to treat-
ment. It is to be expected that outcomes are not within target level for this group of patients,
which may cause a bias in the opposite direction. However, we argue that this bias also occurs
in routine care. Since our aim was to develop a model of determinants that approaches every-
day care, the large study population that we used was valid for its purpose.
Since data were collected through an automated extraction of medical records, it is likely
that there is an effect of poor registration. This is reflected by the large difference in measure-
ment of outcomes in our study population compared to the report on multidisciplinary care.
In the latter study, the practice collected data from their registration themselves, which meant
that they could retrieve misplaced information more easily. The registration bias in our study
may have led to a bias in our study population. Although poor registration may have led to
lower scores on processes of care, in general our population was reasonably well controlled.
This may have decreased the likelihood of finding associations in this study.
Conclusion
Several non-modifiable patient factors could be associated with processes and outcomes of dia-
betes care. The main contributor to improved processes of care was the frequency of diabetes
consultations. However, especially regarding the outcomes of care, associations were small.
Therefore, our results do not support the need for case-mix correction or stratification sug-
gested in previous literature. Accounting for a certain margin of error around the scores with-
out further correction may be more beneficial for users in practice.
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